B
BBLGW
Bone Biologics
14.50
0.000.00%Opening09:30 06/24 EDT
OPEN/PREV CLOSE--/14.50
TODAY RANGE-
VOL0
MARKET CAP--
52 WEEK RANGE8.30-35.95
AVG VOL (3M)663
% TURNOVER0%
TURNOVER--
P/E (TTM)-5.7870
% RANGE--
EPS(TTM)-2.5056
P/E(FORWARD)--
P/B5.57
BVPS2.601
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP--
SHARES OUTSTANDING--
NEXT EARNINGS05/11-05/15
FREE FLOAT--
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·06/08 10:05
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
TipRanks·05/19 12:10
Bone Biologics achieves 29-month shelf life for rhNELL-1
Benzinga·05/14 21:11
Bone Biologics Q1 EPS $(0.43) Beats $(0.54) Estimate
PUBT·05/14 21:02
Bone Biologics Q1 FY26 net loss narrows 24.69% to $765,988
Reuters·03/02 21:36
Bone Biologics posts FY 2025 interest income of USD 122.0k (+119.2%)
Benzinga·02/24 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·01/08 13:40
Bone Biologics summarizes key milestones achieved during 2025
Benzinga·12/23/2025 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·12/23/2025 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga·12/23/2025 13:06
Bone Biologics Extends Shelf Life Of rhNELL‑1 To 24 Months, Meeting Forecasts
TipRanks·12/23/2025 13:05
Bone Biologics receives confirmation rhNELL-1 shelf life extended to 24 months
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.